Third Circuit Shows No Love For Lovenox® Bundling Theory
				Posted  05/6/16
								
				 
								 				By Ankur Kapoor
Citing the well-known maxim that the antitrust laws are concerned with “the protection of competition, not competitors,” the U.S. Court of Appeals for the Third Circuit on Wednesday  for Defendant Sanofi Aventis on Plaintiff Eisai, Inc.’s claim that Sanofi foreclosed 
competition in the market for anticoagulant drugs administered in hospitals.
Eisai alleged that...